Zobrazeno 1 - 10 of 11 pro vyhledávání: '"Sophie Dheur"'
1
Akademický článek
Prefemoral Fat Pad Impingement Syndrome: Correlation between Ultrasonography and Magnetic Resonance Imaging
Autor: Sophie Dheur, Felicie Lorthioir
Publikováno v: Journal of the Belgian Society of Radiology, Vol 108, Iss 1, Pp 61-61 (2024)
Teaching point: Prefemoral fat pad impingement syndrome is one of the fat pad impingements of the knee and can be assessed with ultrasonography.
Externí odkaz: https://doaj.org/article/f0206a1fa87a40d49646a251d618af59
Zobrazit plný text záznamu
3
Akademický článek
Highly Aggressive Metastatic Melanoma Cells Unable to Maintain Telomere Length
Autor: Nikenza Viceconte, Marie-Sophie Dheur, Eva Majerova, Christophe E. Pierreux, Jean-François Baurain, Nicolas van Baren, Anabelle Decottignies
Publikováno v: Cell Reports, Vol 19, Iss 12, Pp 2529-2543 (2017)
Summary: Unlimited replicative potential is one of the hallmarks of cancer cells. In melanoma, hTERT (telomerase reverse transcriptase) is frequently overexpressed because of activating mutations in its promoter, suggesting that telomerase is necessa
Externí odkaz: https://doaj.org/article/5cd459471a4d4d31bf46f48e839eb5df
Zobrazit plný text záznamu
4
Clinical Grade Manufacture of CYAD-101, a NKG2D-based, First in Class, Non–Gene-edited Allogeneic CAR T-Cell Therapy
Autor: Alexandre, Michaux, Sébastien, Mauën, Eytan, Breman, Marie-Sophie, Dheur, Laure, Twyffels, Laura, Saerens, Céline, Jacques-Hespel, Emilie, Gauthy, Sophie, Agaugué, David E, Gilham, Panagiota A, Sotiropoulou
Publikováno v: Journal of Immunotherapy. 45:150-161
Allogeneic chimeric antigen receptor (CAR) T holds the promise of taking this therapeutic approach to broader patient populations while avoiding the intensive manufacturing demands of autologous cell products. One limitation to delivering an allogene
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06c15c3fe4a9d77b6b571e8f8154c040
https://doi.org/10.1097/cji.0000000000000413
Zobrazit plný text záznamu
5
Immunicy-1: Targeting BCMA with Cyad-211 to Establish Proof of Concept of an shRNA-Based Allogeneic CAR T Cell Therapy Platform
Autor: Caroline Lonez, Ahmad-Samer Al-Homsi, Dries Deeren, Nathalie Meuleman, Anne Flament, David E. Gilham, Taiga Nishihori, Marie-Sophie Dheur, Maher Abdul-Hay, Nathalie Braun, Erik Alcantar-Orozco, Gareth J. Morgan, Sébastien Anguille, Jason Brayer, Frederic Lehmann
Publikováno v: Blood. 138:2817-2817
Off-the-shelf allogeneic CAR T cells derived from healthy donor cells have the potential to overcome many of the issues associated with the time-consuming manufacturing of autologous CAR T cells. However, adoptive transfer of allogeneic T cells carri
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::be05f081f3191b86873bae45174073bc
https://doi.org/10.1182/blood-2021-147738
Zobrazit plný text záznamu
6
Co-Expression of an shRNA Targeting MICA/Micb Improves the Clinical Activity of a NKG2D-Based CAR T in Patients with Relapsed / Refractory AML/MDS
Autor: Yves Beguin, David E. Gilham, Erik Alcantar-Orozco, Anne Flament, Caroline Lonez, Dries Deeren, Tara L. Lin, Nathalie Braun, Frederic Lehmann, Eytan Breman, Johan Maertens, Marie-Sophie Dheur
Publikováno v: Blood. 138:408-408
While CAR T cell therapy has delivered impressive clinical efficacy in B cell malignancies, similar levels of clinical activity have not been demonstrated in acute myeloid leukemia (AML). One underlying reason for this lack of translation is the rela
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2777df6c8489949758c4dbddc58bbed0
https://doi.org/10.1182/blood-2021-152413
Zobrazit plný text záznamu
7
Highly Aggressive Metastatic Melanoma Cells Unable to Maintain Telomere Length
Autor: Marie-Sophie Dheur, Nicolas van Baren, Jean-François Baurain, Nikenza Viceconte, Anabelle Decottignies, Christophe Pierreux, Eva Majerova
Publikováno v: Cell Reports, Vol 19, Iss 12, Pp 2529-2543 (2017)
Cell Reports, Vol. 19, no.12, p. 2529-2543 (20 June 2017)
Summary: Unlimited replicative potential is one of the hallmarks of cancer cells. In melanoma, hTERT (telomerase reverse transcriptase) is frequently overexpressed because of activating mutations in its promoter, suggesting that telomerase is necessa
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b5cdd8595471eb8edb813fb0e464308
http://www.sciencedirect.com/science/article/pii/S2211124717307039
Zobrazit plný text záznamu
9
Updated data from alloSHRINK phase I first-in-human study evaluating CYAD-101, an innovative non-gene edited allogeneic CAR-T in mCRC
Autor: Eric Van Cutsem, David E. Gilham, Caroline Lonez, Anne Flament, Sébastien Anguille, Ahmad Awada, Marie-Sophie Dheur, Frederic Lehmann, Hans Prenen, Emilie Cerf, Eytan Breman, Alain Hendlisz, Jeroen Dekervel, Erik Alcantar-Orozco
Publikováno v: Journal of Clinical Oncology. 39:74-74
74 Background: CYAD-101 is a first-in-class, non-gene edited allogeneic CAR T-cell product that combines the broad breadth of tumor targeting of the NKG2D-based chimeric antigen receptor (CAR) with a peptide-based approach that controls graft versus
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b0d4fd184fcf00eaa34ff1c9923eb2b6
https://doi.org/10.1200/jco.2021.39.3_suppl.74
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje